Excretion and Metabolism of Lersivirine (5- benzene-1,3-dicarbonitrile), a Next-Generation Non-Nucleoside Reverse Transcriptase Inhibitor, after Administration of [14C]Lersivirine to Healthy Volunteers

Published 2010 View Full Article

Authors

Keywords

Journal

DRUG METABOLISM AND DISPOSITION

Volume 38, Issue 5, Pages 789-800

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Online

2010-02-03

DOI

10.1124/dmd.109.031252

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

DRUG METABOLISM AND DISPOSITION

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Publish scientific posters with Peeref

Create your own webinar